This Article  • References  • Full text PDF  • Reply to article  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in this journal  Social Bookmarking   What's this?

Report of a Case

ELI B. HALPERN, M.D.; MORRIS F. HELLER, M.D.

Arch Otolaryngol. 1961;73(6):675-677.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

The ototoxicity of parenterally administered neomycin is now well recognized. There are, however, no reports of ototoxicity from orally administered neomycin. We believe the patient to be described in our report is the first case to be recorded in the literature of sensorineural deafness resulting from the oral administration of neomycin sulfate.

Greenwood¹ reviewed the literature summarizing 20 cases of parenteral neomycin ototoxicity and reporting 1 additional case. He also described the clinical and histopathological ototoxicity of neomycin. In these cases the minimum amount of intramuscular neomycin which produced deafness was 8 gm. administered over 4 days. The onset of the hearing loss was 10 days after therapy was started, and bilateral sensorineural deafness was complete in 3 months.

The largest amount used was 45 gm. given over 42 days. The onset of the hearing loss was approximately 35 days after therapy was initiated (35 gm. given) and deafness . . . [Full Text PDF of this Article]

Author Affiliations
NEW YORK

Resident, Department of Otolaryngology (Dr. Halpern); Assistant Attending Otolaryngologist, Chief, Audiology Clinic (Dr. Heller), The Mount Sinai Hospital.

Footnotes
Submitted for publication Aug. 19, 1960.

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?